Healthcare Leaders Hub

🏠Home 📰News 📝Blog 🎬Videos Advertise Login

Your trusted source for pharmaceutical news, expert insights, and healthcare innovation.

💼𝕏 👥▶️

Content

📰News
📝Blog
🎬Videos

Company

🏠Home
🏢About Us
📧Contact

© 2026 PharmaVoice. All rights reserved. Empowering healthcare leaders.

Privacy Policy•Terms of Service

Pharma Tech

AstraZeneca shares slump after $400bn BMS merger rumours

Aug 3, 2026, 3:03 PM

Read Full Article → AstraZeneca shares slump after $400bn BMS merger rumours

AstraZeneca shares slump after $400bn BMS merger rumours

Translate article text

Choose a language and wait for the translated text.

One of the largest global pharma companies would be created if a deal were to materialise.

AstraZeneca shares slump after $400bn BMS merger rumours | PharmaVoice